ATG-GCSF in New Onset Type 1 Diabetes

NCT02215200 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

89

Enrollment

NIH

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Anti-Thymocyte Globulin (ATG)
DRUG: Granulocyte colony stimulating factor (GCSF)
DRUG: Placebo (for ATG)
DRUG: Placebo (for GCSF)

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]